What changed on 1 May 2026. The U.S. FDA's "Guidance for Industry: Preparation of Food Contact Substance Notifications and Food Contact Notifications" was updated on 1 May 2026. The principal change: for any new food-contact substance (FCS), applicants must now include QSPR (Quantitative Structure-Property Relationship) migration modeling — software-based prediction of diffusion and partition coefficients — in addition to the historical in-vivo and in-vitro migration tests. The rule applies to all new FCSN submissions filed after 1 May 2026; existing FCNs (Food Contact Notifications) remain valid but require QSPR re-confirmation at the next substantial change or re-authorisation cycle.
Why this matters for B2B kitchenware exports. A new polymer entering the U.S. market as a food-contact article (e.g. a novel bamboo-fibre composite, PLA blend, or recycled-PET grade) now requires an FCN that includes: (a) in-silico QSPR outputs (typically EPA EPI Suite, SmitTA, or OECD QSAR Toolbox), (b) confirmation against the FDA Threshold of Regulation (TOR, 0.5 ppb dietary concentration), and (c) analytical migration data from an FDA-cleared lab (e.g. Eurofins, Intertek, SGS, NSF). This expands both the documentation footprint and the lead time.
| Item | Pre-May 2026 (typical) | Post-May 2026 (QSPR-required) | Delta |
|---|---|---|---|
| Lead time, FCN first review | 8–11 months | 11–14 months | +3 months |
| FCN fee (per FCS) | $3,200 (small business $1,600) | $3,200 + ~$8,000–15,000 QSPR modelling | +250% to +470% |
| Migration testing rounds | 2 (simulants A & E) | 2 + 1 QSPR cross-check | +1 round |
| Documentation pages | 80–120 | 150–220 | +75% |
Implications for Chinese B2B exporters. For existing product lines that already have an effective FCN (e.g. commonly used 304SS, PP #5, Tritan™, silicone LFGB), there is no immediate action — the FCN transfers with the product. But for any new product or reformulation (e.g. a new colour masterbatch, a new biopolymer, a recycled-content material with different process chemistry), the FCN cycle is now 4–6 months longer and 3–5x more expensive. Small-volume Chinese exporters (annual U.S. revenue < $5M) should consider: (i) partnering with an established U.S. masterbatch supplier with a current FCN, (ii) using a "no-FCN-required" formulation by selecting from FDA's Inventory of Effective Food Contact Substance Notifications (effective list maintained at fda.gov), or (iii) accepting a longer U.S. market-entry window (12–18 months vs 8–11 months).
WanLong practice. All WanLong products sold into the U.S. carry a current FCN cross-reference in their spec sheet. For new product briefs, our regulatory team pre-checks the FDA Inventory of Effective FCSNs (last updated 30 June 2026) and rejects briefs that would trigger a new QSPR submission unless the order volume justifies the 6–8 week QSPR add-on cost. Source: FDA Inventory of Effective FCSNs; FDA Guidance for Industry (May 2026 revision); 21 CFR 170.39 (Threshold of Regulation).
Source: FDA Guidance for Industry: Preparation of Food Contact Substance Notifications (May 2026 revision); 21 CFR Parts 170–199; FDA Inventory of Effective FCSNs (June 2026 snapshot); EPA EPI Suite QSPR model v4.11; OECD QSAR Toolbox v4.5
Want a compliance or sourcing brief on this topic?
We prepare country-specific impact analyses for our buyers. Share your target market, product category, and timeline — we will send back a tailored brief.
Request a Brief